Vanda Pharmaceuticals | VNDA - EPS Earnings Per Share

Stock Price
7.22
Daily Change
-0.10 -1.37%
Monthly
-18.05%
Yearly
65.22%
Q2 Forecast
7.02

Vanda Pharmaceuticals reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -2.11 1.6 Dec/2025
Novartis USD 1.54 0.48 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.53 1.38 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Veracyte USD 0.53 0.02 Dec/2025